We are all too familiar with viral outbreaks and the constant threat that they pose to human health. To date, Zika virus has been reported in 86 countries, with large outbreaks in several, most notably Brazil.
Lead researchers Dr. Marciano Paes, of Oswaldo Cruz Institute-Fiocruz and Dr. Kissila Rabelo, of Rio de Janeiro State University in Brazil, stated that “we observed Zika spread rapidly in Brazil and saw with our own eyes the situation of pregnant women. It was really impactful and made us question how the scientific community could know so little about this disease. So as research group that already works with arboviruses, we dedicated ourselves to understanding the pathogenesis of this disease.”
This study was a joint effort by a team of scientists, biologists, physicians and nurses from different institutions in Brazil. The team examined placenta samples of pregnant women from during the peak of the Zika outbreak in Brazil in 2015-2016. They took samples from 5 women who had not been infected with Zika virus and 10 women who had been infected with Zika virus, 5 of which had given birth to babies with microcephaly and 5 without microcephaly.
One of the key functions of the placenta is to protect a fetus during pregnancy, and it is typically very effective at preventing viral infections. The results of this study, however, showed that Zika was able to bypass these efforts and continue to replicate in the placenta tissue, creating a robust inflammatory environment that could last for months after the beginning of infection.
The researchers were able to determine that this inflammatory environment was a result of an exacerbated response by several immune cells, such as macrophages, CD8+ T lymphocytes, and cytokines that lead to cytotoxicity. They further showed that this can cause pathological changes in the tissue and increased vascular permeability, which in some cases, impact the fetus development.
Rabelo says, that “these findings will be very useful for scientists to establish an infection profile and further understand the immune response caused by Zika virus.” She adds that “this could generate countless developments, from a basis for the detection of plasma biomarkers to the development of drugs and vaccines. All of which are vital for controlling future zika outbreaks, which according to epidemiologists are likely to happen again.”
REPUBLISHING GUIDELINES: Open access and sharing research is part of Frontiers’ mission. Unless otherwise noted, you can republish articles posted in the Frontiers news blog — as long as you include a link back to the original research. Selling the articles is not allowed.
By Jillian Hobson, science writer
